Marie-Ange Mouret-Reynier

ScholarGPS® ID: 42814494445919

Affiliation

University of Clermont Auvergne, Clermont-Ferrand, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

177

Predicted Citations

5,245

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial. (journal article) Bidard, Francois Clement \| Berger, Frederique \| Arnedos, Monica \| Mouret-Reynier, Marie-Ange \| Tredan, Olivier \| Sabatier, Renaud \| Jacot, William \| Massard, Vincent \| De La Motte Rouge, Thibault \| Gligorov, Joseph \| ... \| Kiavue, Nicolas Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS1139-TPS1139 (2024). 10.1200/JCO.2024.42.16_suppl.TPS1139 Cite \| Source
4MO Neoadjuvant letrozole and palbociclib versus chemotherapy in the NeoPAL study: A translational analysis (journal article) Cottu, P.H. \| Kieffer, Y. \| Lemonnier, J. \| D'Hondt, V. \| Duhoux, F.P. \| Callens, C. \| Gentien, D. \| Desmoulins, I. \| Mouret-Reynier, M-A. \| Levy, C. \| ... \| Vincent-Salomon, A. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103014 Cite \| Source
PO143 MODELING AN ANNOUNCEMENT PATHWAY FOR PATIENTS ENTERING METASTATIC DISEASE CLINICAL ISSUES: SUPPORTIVE AND PALLIATIVE CARE (journal article) Mouret-Reynier, Marie-Ange \| Dalenc, Florence \| Guiu, Severine \| Quenel-Tueux, Nathalie The Breast, volume 71 (2023). 10.1016/S0960-9776(23)00707-5 Cite \| Source
LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early-stage breast cancer at very low risk of metastasis. (journal article) Deluche, Elise \| Michiels, Stefan \| Fric, Daniele \| Perrin, Christophe \| Bailleux, Caroline \| Bachelot, Thomas \| Ko Kivok Yun, Pascal \| De Rauglaudre, Gaetan \| Mouret-Reynier, Marie-Ange \| Le Scodan, Romauld \| ... \| Andre, Fabrice Journal of Clinical Oncology, volume 41, issue 16_suppl, pages TPS615-TPS615 (2023). 10.1200/JCO.2023.41.16_suppl.TPS615 Cited by (2) \| Cite \| Source
20P Spatial analysis of residual tumor tissue provides new clues for post-neoadjuvant treatment approaches in triple-negative breast cancer (journal article) Kossai, M. \| Jahanmohan, J. Passildas \| Lacrampe, N. \| Molnar, I. \| Mouret Reynier, M.A. \| Abrial, C. \| Durando, X. \| Penault-Llorca, F. \| Radosevic, N. ESMO Open, volume 8, issue 1, pages 101244- (2023). 10.1016/j.esmoop.2023.101244 Cite \| Source
Recommandations de prise en charge des inhibiteurs de PARP en pratique infirmière - Retour sur les résultats d’un consensus national Delphi (journal article) Dielenseger, Pascale \| Matta, Carla \| Angelergues, Antoine \| Augereau, Paule \| Berton, Dominique \| Fabbro, Michel \| Falandry, Claire \| Follana, Philippe \| Gladieff, Laurence \| Joly, Florence \| ... \| Selle, Frédéric Bulletin Infirmier du Cancer, volume 23, issue 1, pages 45-58 (2023). 10.1684/bic.2023.233 Cite \| Source
Gestion pratique des inhibiteurs de PARP : Un consensus national DELPHI (journal article) Selle, Frédéric \| Boffa, Jean-Jacques \| Etienne, Gabriel \| Angelergues, Antoine \| Augereau, Paule \| Berton, Dominique \| Dielenseger, Pascale \| Fabbro, Michel \| Falandry, Claire \| Follana, Philippe \| ... \| Floquet, Anne Bulletin du Cancer, volume 109, issue 12, pages 1245-1261 (2022). 10.1016/j.bulcan.2022.06.011 Cite \| Source
Factors associated with enrolment in clinical trials among women with early-stage breast cancer (journal article) Presti, D. \| Havas, J. \| Soldato, D. \| Lapidari, P. \| Martin, E. \| Pistilli, B. \| Jouannaud, C. \| Emile, G. \| Rigal, O. \| Fournier, M. \| ... \| Di Meglio, A. ESMO Open, volume 7, issue 3, pages 100513- (2022). 10.1016/j.esmoop.2022.100513 Cited by (2) \| Cite \| Source
Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort (journal article) Bringuier, M. \| Carton, M. \| Levy, C. \| Patsouris, A. \| Pasquier, D. \| Debled, M. \| Rigal, O. \| Jacot, W. \| Gonçalves, A. \| Desmoulins, I. \| ... \| Baldini, C. Breast Cancer Research and Treatment, volume 191, issue 3, pages 577-587 (2022). 10.1007/s10549-021-06467-2 Cited by (3) \| Cite \| Source
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial (journal article) Harter, Philipp \| Mouret-Reynier, Marie Ange \| Pignata, Sandro \| Cropet, Claire \| González-Martín, Antonio \| Bogner, Gerhard \| Fujiwara, Keiichi \| Vergote, Ignace \| Colombo, Nicoletta \| Nøttrup, Trine Jakobi \| ... \| Ray-Coquard, Isabelle Gynecologic Oncology, volume 164, issue 2, pages 254-264 (2022). 10.1016/j.ygyno.2021.12.016 Cited by (56) \| Cite \| Source
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database (journal article) Carausu, Marcela \| Carton, Matthieu \| Cabel, Luc \| Patsouris, Anne \| Levy, Christelle \| Verret, Benjamin \| Pasquier, David \| Debled, Marc \| Gonçalves, Anthony \| Desmoulins, Isabelle \| ... \| Bozec, Laurence Therapeutic Advances in Medical Oncology, volume 14 (2022). 10.1177/17588359221077082 Cited by (2) \| Cite \| Source
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR) (journal article) Trédan, Olivier \| Provansal, Magali \| Abdeddaim, Cyril \| Lardy-Cleaud, Audrey \| Hardy-Bessard, Anne-Claire \| Kalbacher, Elsa \| Floquet, Anne \| Venat-Bouvet, Laurence \| Lortholary, Alain \| Pop, Oana \| ... \| Ray-Coquard, Isabelle Gynecologic Oncology, volume 164, issue 1, pages 18-26 (2022). 10.1016/j.ygyno.2021.09.024 Cited by (4) \| Cite \| Source
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer (journal article) Corbaux, Pauline \| Lardy-Cleaud, Audrey \| Alexandre, Marie \| Fontanilles, Maxime \| Lévy, Christelle \| Viansone, Alessandro Adriano \| Mailliez, Audrey \| Debled, Marc \| Goncalves, Anthony \| Le Du, Fanny \| ... \| Bachelot, Thomas Breast Cancer Research and Treatment, volume 191, issue 1, pages 191-207 (2022). 10.1007/s10549-021-06382-6 Cite \| Source
Population pharmacokinetics and exposure–response relationship of trastuzumab and bevacizumab in early-stage breast cancer (journal article) Petitcollin, A. \| Azzopardi, N. \| Pierga, J. Y. \| Ternant, D. \| Navarro-Teulon, I. \| Desvignes, C. \| Mouret-Reynier, M. A. \| Coudert, B. \| Paintaud, G. European Journal of Clinical Pharmacology, volume 77, issue 12, pages 1861-1873 (2021). 10.1007/s00228-021-03179-w Cited by (2) \| Cite \| Source
Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database (journal article) Annonay, Mylène \| Gauquelin, Lisa \| Geiss, Romain \| Ung, Mony \| Cristol-Dalstein, Laurence \| Mouret-Reynier, Marie-Ange \| Goncalves, Anthony \| Abadie-Lacourtoisie, Sophie \| Francois, Eric \| Perrin, Christophe \| ... \| Delaloge, Suzette The Breast, volume 60 (2021). 10.1016/j.breast.2021.09.011 Cited by (6) \| Cite \| Source
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis (journal article) Gaillard, T. \| Carton, M. \| Mailliez, A. \| Desmoulins, I. \| Mouret-Reynier, M.A. \| Petit, T. \| Leheurteur, M. \| Dieras, V. \| Ferrero, J.M. \| Uwer, L. \| ... \| Hequet, D. European Journal of Cancer, volume 158 (2021). 10.1016/j.ejca.2021.09.021 Cite \| Source
260 Impact of BRCA & PD-L1 in EOC patients receiving standard 1st line therapy +/- Pembrolizumab: Exploratory analyses from the NeoPembrOV Study (GINECO) (conference) Le Saux, O \| Savoye, AM \| Mouret-Reynier, MA \| Schiffler, C \| Derbel, O \| Isabelle, T \| Kalbacher, E \| Gouerant, S \| Martinez, A \| Cornila, C \| ... \| Ray-Coquard, I ESGO 2021 Congress (2021) 10.1136/ijgc-2021-ESGO.369 Cite \| Source
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer (journal article) Bortolini Silveira, Amanda \| Bidard, François-Clément \| Tanguy, Marie-Laure \| Girard, Elodie \| Trédan, Olivier \| Dubot, Coraline \| Jacot, William \| Goncalves, Anthony \| Debled, Marc \| Levy, Christelle \| ... \| Pierga, Jean-Yves npj Breast Cancer, volume 7, issue 1 (2021). 10.1038/s41523-021-00319-4 Cited by (27) \| Cite \| Source
134P Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC) (journal article) Presti, D. \| Havas, J. \| Soldato, D. \| Lapidari, P. \| Martin, E. \| Pistilli, B. \| Martin, A-L. \| Everhard, S. \| Jouannaud, C. \| Levy, C. \| ... \| Di Meglio, A. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.415 Cite \| Source
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME) (journal article) Dano, D. \| Lardy-Cleaud, A. \| Monneur, A. \| Quenel-Tueux, N. \| Levy, C. \| Mouret-Reynier, M.-A. \| Coudert, B. \| Mailliez, A. \| Ferrero, J.-M. \| Guiu, S. \| ... \| Gonçalves, A. ESMO Open, volume 6, issue 4, pages 100220- (2021). 10.1016/j.esmoop.2021.100220 Cited by (15) \| Cite \| Source